O uso de hormônios após a menopausa
três lustros de três estudos e atualidade de Drummond
Resumo
Guay MP, Dragomir A, Pilon D, Moride Y, Perreault S. Changes in
pattern of use, clinical characteristics and persistence rate of hormone
replacement therapy among postmenopausal women after the WHI
publication. Pharmacoepidemiol Drug Saf. 2007;16(1):17-27.
Aquino EM, Barreto SM, Bensenor IM, et al. Brazilian
Longitudinal Study of Adult Health (ELSA-Brasil): objectives and
design. Am J Epidemiol. 2012;175(4):315-24.
Aquino EM, Almeida MD, Menezes GM, et al. Postmenopausal
hormone therapy in the Brazilian Longitudinal Study of Adult
Health (ELSA-Brasil): who still uses it? Pharmacoepidemiol Drug
Saf. 2016;25(6):609-17.
Clapauch R, Athayde A, Meirelles RMR, et al. Terapia
hormonal da menopausa: posicionamento do Departamento
de Endocrinologia Feminina e Andrologia da SBEM em
2004 [Hormonal therapy of menopause: 2004 position of the
Department of Female Endocrinology and Andrology of the
Brazilian Society of Endocrinology and Metabolism]. Arq Bras
Endocrinol Metabol. 2005;49(3):449-54.
Pardini D. Terapia de reposição hormonal na menopausa
[Hormone replacement therapy in menopause]. Arq Bras
Endocrinol Metabol. 2014;58(2):172-81.
Oliveira VM, Aldrighi JM, Gebara OCE. “E, agora José? Como
ficam os riscos do câncer de mama e do infarto do miocárdio
nas usuárias de terapia hormonal após a menopausa? Rev Assoc
Med Bras. 2011;57(4):361-4.
Referências
Lotufo PA. O que o fracasso da terapia de reposição hormonal nos ensinou? [What the failure of the hormonal therapy in taught them?] Diagn Tratamento. 2002;7(1):3-4.
Lotufo PA. Ainda sobre o fracasso da terapia de reposição hormonal em mulheres. Diagn Tratamento. 2002;7(4):3-4.
Lima GR, Fernandes CE. Ainda sobre o fracasso da terapia de reposiçäo hormonal em mulheres [Still on the failure of the hormonal therapy of reposiçäo in women]. Diagn Tratamento. 2003;8(1):3-8.
Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 1998;280(7):605-13.
Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses’ health study. N Engl J Med. 1991;325(11):756-62.
Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-33.
Beral V, Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet. 2003;362(9382):419-27.
